Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-09-26
1992-09-01
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 28, 514 53, 536 168, 536 174, 536 181, A61K 3170, C07H 1700
Patent
active
051439069
ABSTRACT:
Kedarcidin chromophore, a non-protein chromophore isolated from kedarcidin antitumor antibiotic, is obtained from purified or partially purified kedarcidin by solvent extraction and chromatographic procedures. The chromophore is characterized and found to contain substantially all of the antitumor activity of kedarcidin.
REFERENCES:
patent: 3706729 (1972-12-01), Batcho et al.
patent: 5001112 (1991-03-01), Hofstead et al.
Otto D. Hensens et al., The Journal of Antibiotics, 1989, 42, 761-768.
H. Suzuki et al., Biochemical and Biophysical Research Communications, 1980, 94, 255-261.
Bristol--Myers Squibb Company
Brown Johnnie R.
Morse David M.
Rahman A.
LandOfFree
Kedarcidin antitumor chromophore and pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kedarcidin antitumor chromophore and pharmaceutical composition , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kedarcidin antitumor chromophore and pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-767812